Insulet Corp. (PODD) Tops Q3 EPS by 1c

Insulet Corp. (NASDAQ: PODD) reported Q3 EPS of $0.00, $0.01 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $75 million versus the consensus estimate of $75.3 million.

Insulet Corp. sees Q4 2014 revenue of $76-81 million, versus the consensus of $80.94 million.

For earnings history and earnings-related data on Insulet Corp. (PODD) click here.

You May Also Be Interested In

• Attention Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Bloom Energy Corporation (NYSE: BE); Erasca, Inc. (NASDAQ: ERAS); and Insulet Corporation (NASDAQ: PODD): Grabar Law Offic
• Reading (RDI) Tops Q2 EPS by 4c
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery